News & Updates
Filter by Specialty:

Air pollution, rainfall influence outpatient visits for atopic dermatitis in SG
Ambient particulate matter concentrations and rainfall are independently associated with the number of outpatient visits for atopic dermatitis in Singapore, according to a study.
Air pollution, rainfall influence outpatient visits for atopic dermatitis in SG
25 May 2024
Switching from cetuximab to bevacizumab associated with acceptable survival, reduced derm toxicity in mCRC
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab leads to acceptable survival outcomes and a reduction in severe dermatological toxicities in patients with RAS wild-type (RASwt) metastatic colorectal cancer (mCRC), according to the results of a single-arm phase II HYBRID trial.
Switching from cetuximab to bevacizumab associated with acceptable survival, reduced derm toxicity in mCRC
23 Apr 2024
Lower VTE risk seen in atopic dermatitis vs other inflammatory diseases
Atopic dermatitis (AD) does not seem to induce an increase in the risk of venous thromboembolism (VTE) when considering underlying risk factors, suggests a study. Moreover, patients with AD show a lower VTE risk than those with rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA), or ankylosing spondylitis (AS).
Lower VTE risk seen in atopic dermatitis vs other inflammatory diseases
22 Apr 2024
Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis
Analysing molecular signatures from active skin lesions aids in the stratification of patients with contact dermatitis (CD) and helps identify those with allergic CD, suggests a study.
Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis
19 Apr 2024
Oral minoxidil may be a viable alternative to topical treatment for male pattern baldness
Low-dose oral minoxidil demonstrates comparable efficacy to 5% topical minoxidil in the treatment of androgenetic alopecia in men, offering a viable option for those who prefer oral therapy or those who poorly tolerate topical treatment, as shown in a study.